Double Board Guangdong Topstar Technology (300607.SZ): Cooperation with Huawei is in the preliminary start-up stage and has not generated actual revenue.
Tospur (300607.SZ) issued an announcement on the abnormal fluctuations of stock price, stating that the company signed a cooperation agreement with Huawei on November 15, 2024...
Guangdong Topstar Technology (300607.SZ) announced in a stock price abnormality notice that on November 15, 2024, the company signed a memorandum of cooperation with Huawei (Shenzhen) Global Intelligent Industry Innovation Center. The cooperation is in the preliminary stage and has not generated actual revenue, so it will not affect the company's performance. The subsequent progress of the cooperation may face unpredictable factors or force majeure such as macroeconomic changes, industry policy changes, market competition, and technological iteration, leading to uncertainty in the impact on the company's future performance. We encourage investors to make rational investments and pay attention to risks.
Related Articles

The mid-term growth momentum is underestimated. Goldman Sachs Group, Inc. reaffirmed a "buy" rating on Ulta Beauty (ULTA.US).

AINNOVATION (02121) spent approximately HK$2.1431 million on repurchasing 376,900 shares on December 31st.

Encore Medical, a developer of cardiac implants, priced its IPO at $5 per share, aiming to raise $15 million.
The mid-term growth momentum is underestimated. Goldman Sachs Group, Inc. reaffirmed a "buy" rating on Ulta Beauty (ULTA.US).

AINNOVATION (02121) spent approximately HK$2.1431 million on repurchasing 376,900 shares on December 31st.

Encore Medical, a developer of cardiac implants, priced its IPO at $5 per share, aiming to raise $15 million.






